Osteoblast-derived CCN1 : A paracrine regulator of osteoclastogenesis? by Wang, W. et al.
Abstract Submission to the 3rd Joint Meeting of ECTS & IBMS
Cell biology: osteoclasts and bone resorption
ECTS/IBMS11-ABS-2010
OSTEOBLAST-DERIVED CCN1: A PARACRINE REGULATOR OF OSTEOCLASTOGENESIS?
W. Wang 1,*, N. Schuetze 2, R. M. Aspden 1, J. C. Crockett 1
1Musculoskeletal Research Programme, Division of Applied Medicine, UNIVERSITY OF ABERDEEN, Aberdeen, United
Kingdom, 2Orthopedic Center for Musculoskeletal Research, University of Wuerzburg, Wuerzburg, Germany
Abstract: CCN1 (CYR61) is a member of the CCN protein family (CYR61, CTGF, Nov, Wisp-1, Wisp-2 and Wisp-3)
which have important roles in many different processes including angiogenesis, inflammation, remodelling of extracellular
matrix and tumorigenesis. In bone, CCN1 increases osteoblastogenesis via Wnt3A signalling and activation of β-catenin
which, in turn, upregulates CCN1 expression. The exact role of CCN1 in osteoclast physiology is not known but we have
recently shown that recombinant human (rh)CCN1 inhibits osteoclastogenesis in vitro. The aim of this study was to
determine whether osteoblast-derived CCN1 may mediate this inhibitory effect on osteoclast formation.
In agreement with our previous observations, rhCCN1 inhibited human and mouse osteoclast formation in a
concentration-dependent manner. We found, using quantitative RT-PCR and western blot analysis, that CCN1 was
expressed in both human and mouse osteoblasts and osteoclasts at both mRNA and protein levels. We generated an
expression construct to specifically overexpress CCN1 in osteoblasts under the control of the -2.3kb fragment of the rat
Col-1α1 promoter and, when transfected (using the Invitrogen Neon electroporation system) into mouse calvarial
osteoblasts, this resulted in 6-10 times higher expression of CCN1 compared to untransfected control cells. Incorporation
of CCN1-specific siRNA reduced CCN1 expression to between 12.5% and 50% of control osteoblast cultures. These
mouse osteoblasts (with overexpressed or knocked down CCN1) were co-cultured for 14 days with murine bone marrow
cells in the presence of 10-8 M VitD3 and 10-6 M PGE2. Compared with co-cultures with untransfected osteoblasts,
overexpression of CCN1 in osteoblasts decreased the formation of TRAP positive multinucleated osteoclast-like cells,
while siRNA mediated knockdown of CCN1 in the osteoblasts resulted in increased osteoclast-like cell formation. To
determine whether this effect was as a result of secreted CCN1 or direct cell-cell contact, we performed Transwell co-
cultures with murine osteoblasts and murine RAW264.7 cells in the presence of rmRANKL (20ng/ml) for 3 days. Similarly
to the direct contact co-cultures, overexpression of CCN1 in the osteoblasts reduced osteoclast-like cell formation
whereas CCN1 knockdown stimulated osteoclast-like cell formation compared to control cultures.
Taken together these data show that, osteoblast-derived CCN1 is a secreted negative regulator of osteoclastogenesis.
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